Dana-Farber Brigham Cancer Center opens new facility in Foxborough

Dana-Farber Brigham Cancer Center is opening a new facility in Foxborough, MA on August 11, 2022. The 30,000 square foot space, located at 22 Patriot Place, provides world-class cancer care to patients in southern Massachusetts and Rhode Island.

This Foxborough cancer facility offers medical oncology and hematology care, blood transfusions, clinical trials, and pharmacy. In the coming months, the center will also offer genetic counseling, palliative care and psychosocial support and survivorship. Brigham and Women's Hospital, located in the adjacent building, offers clinical lab and imaging services.

This new facility has 28 infusion bays, 14 exam rooms, and important support services including access to nutrition and social work services.

"We are so pleased that patients in southern Massachusetts and Rhode Island will now have access to the same services and resources provided to Dana-Farber patients in Boston - including many clinical trials - while maintaining the comfort and convenience of their local community," said Craig Bunnell, MD, Chief Medical Officer, Dana-Farber.

"We are delighted to bring Dana-Farber Brigham Cancer Center services to residents in this region, which will allow our specialists to provide care that patients need in a convenient setting, closer to home," said Charles A. Morris, MD, MPH, deputy chief medical officer, Brigham and Women's Hospital.

Free parking and valet service is available for patients. An onsite cafe in the building adjacent to this new facility has seating overlooking the entrance of Gillette Stadium and is also available to patients and their companions. Additional restaurants and coffee options, as well as shopping and dining, are located within walking distance.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.